BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4093982)

  • 1. Domain association in immunoglobulin molecules. The packing of variable domains.
    Chothia C; Novotný J; Bruccoleri R; Karplus M
    J Mol Biol; 1985 Dec; 186(3):651-63. PubMed ID: 4093982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers.
    Novotný J; Haber E
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4592-6. PubMed ID: 3927286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
    Vargas-Madrazo E; Paz-García E
    J Mol Recognit; 2003; 16(3):113-20. PubMed ID: 12833565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved aromatic residues as determinants in the folding and assembly of immunoglobulin variable domains.
    Campion SR
    Mol Immunol; 2016 Feb; 70():63-71. PubMed ID: 26742085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1.
    Braden BC; Souchon H; Eiselé JL; Bentley GA; Bhat TN; Navaza J; Poljak RJ
    J Mol Biol; 1994 Nov; 243(4):767-81. PubMed ID: 7966295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular anatomy of the antibody binding site.
    Novotný J; Bruccoleri R; Newell J; Murphy D; Haber E; Karplus M
    J Biol Chem; 1983 Dec; 258(23):14433-7. PubMed ID: 6643494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
    Rinfret A; Horne C; Dorrington KJ; Klein M
    J Immunol; 1985 Oct; 135(4):2574-81. PubMed ID: 3928754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthogonal packing of beta-pleated sheets in proteins.
    Chothia C; Janin J
    Biochemistry; 1982 Aug; 21(17):3955-65. PubMed ID: 6751382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant.
    Steipe B; Plückthun A; Huber R
    J Mol Biol; 1992 Jun; 225(3):739-53. PubMed ID: 1602480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Fab assembly: the interface residues between CH1 and CL.
    Padlan EA; Cohen GH; Davies DR
    Mol Immunol; 1986 Sep; 23(9):951-60. PubMed ID: 3097521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major antigen-induced domain rearrangements in an antibody.
    Stanfield RL; Takimoto-Kamimura M; Rini JM; Profy AT; Wilson IA
    Structure; 1993 Oct; 1(2):83-93. PubMed ID: 8069628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
    Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABangle: characterising the VH-VL orientation in antibodies.
    Dunbar J; Fuchs A; Shi J; Deane CM
    Protein Eng Des Sel; 2013 Oct; 26(10):611-20. PubMed ID: 23708320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a diabody, a bivalent antibody fragment.
    Perisic O; Webb PA; Holliger P; Winter G; Williams RL
    Structure; 1994 Dec; 2(12):1217-26. PubMed ID: 7704531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.